MAPT and Alzheimer disease: We further explored a characteristic of p-tau that might be of critical significance in AD disease mechanism and drug discovery, that is, amelioration of the phosphorylation-dependent neurotoxicity of tau by apomorphine, a prescription drug previously found in our pilot screen to inhibit p-tau cytotoxicity in vitro [58].